Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ADVANCED ENERGY INDUSTRIES INCAEIS · Entity 3497 | Director | May 07, 2026 | May 08, 2026 |
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ADVANCED ENERGY INDUSTRIES INC
Report date May 07, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 587 |
Reported balance
After 2026-05-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 587 · Balance 587 F1: Represents an annual grant of restricted stock units to the reporting person on May 7, 2026 as the equity portion of the non-employee directors' retainer for Board services under the 2023 Amended and Restated Omnibus Incentive Plan. The restricted stock units vest on the one-year anniversary of the grant date contingent upon the reporting person's continued service as director upon such date. F2: Restricted stock units are not exercisable and do not have an expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an annual grant of restricted stock units to the reporting person on May 7, 2026 as the equity portion of the non-employee directors' retainer for Board services under the 2023 Amended and Restated Omnibus Incentive Plan. The restricted stock units vest on the one-year anniversary of the grant date contingent upon the reporting person's continued service as director upon such date.
F2: Restricted stock units are not exercisable and do not have an expiration date.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.6103 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 0.5429 · Balance 5.6103 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.5195 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 0.6503 · Balance 5.5195 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.1836 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 0.8852 · Balance 5.1836 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.486 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 1.0022 · Balance 5.486 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 4.2988 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 1.6637 · Balance 4.2988 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ESS Tech, Inc.
Report date October 08, 2021 · Filed October 13, 2021
Section 16 reporting ended · disclosed 2021-10-13. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
NOVANTA INC
Report date September 01, 2016 · Filed September 06, 2016
Section 16 reporting ended · disclosed 2016-09-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 477,961 |
Ending reported balance
After 2016-09-01 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2016-09-01 · Exercise / conversion · Acquired 15,310 · Balance 473,899 Row 2 · 2016-09-01 · Tax withholding · Disposed 7,204 · Balance 466,695 Row 3 · 2016-09-01 · Exercise / conversion · Acquired 15,186 · Balance 481,881 Row 4 · 2016-09-01 · Tax withholding · Disposed 7,146 · Balance 474,735 Row 5 · 2016-09-01 · Exercise / conversion · Acquired 6,094 · Balance 480,829 Row 6 · 2016-09-01 · Tax withholding · Disposed 2,868 · Balance 477,961 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2016-09-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2016-09-01 · Exercise / conversion · Disposed 15,310 · Balance 0 F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit. F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2016-09-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2016-09-01 · Exercise / conversion · Disposed 15,186 · Balance 0 F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit. F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2016-09-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2016-09-01 · Exercise / conversion · Disposed 6,094 · Balance 0 F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit. F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit.
F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2024 Filed Apr 1, 2024 21:33 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.2345 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010436 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.2345 Underlying: Common Stock · 1.2345 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:33 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.9644 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010436 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.9624 Underlying: Common Stock · 0.9644 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:33 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.9644 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010436 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.9511 Underlying: Common Stock · 0.9644 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:33 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.476 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010436 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.9143 Underlying: Common Stock · 0.476 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 22:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 7,500 | $69.00 | $517,500.00 |
DisclosureSEC source: 0001437749-24-007009 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,278 Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 1.9887 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006512 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.998 Underlying: Common Stock · 1.9887 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006512 · rdgdoc.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 593 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006512 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,777 F1 · shares: These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 1/3 upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next two years. F2 · price: Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 22:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034350 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.9867 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 22:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034350 · rdgdoc.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034350 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.4383 Underlying: Common Stock · 2 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034350 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 23:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 2,772 | $0.00 Strike: $54.65 | $0.00 |
DisclosureSEC source: 0001437749-23-034244 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,772 Underlying: Common Stock · 2,772 shares Expires 2028-12-08 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 23:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 512 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034244 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,181 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.5871 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033502 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6 Underlying: Common Stock · 1.5871 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.0385 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033502 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8 Underlying: Common Stock · 1.0385 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.4433 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025198 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.4 Underlying: Common Stock · 1.4433 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.944 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025198 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7.4 Underlying: Common Stock · 0.944 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:28 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.2968 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016641 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.96 Underlying: Common Stock · 1.2968 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:28 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8464 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016641 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.46 Underlying: Common Stock · 0.8464 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001437749-23-013942 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2023-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 7,500 | $65.74 | $493,042.50 |
DisclosureSEC source: 0001437749-23-013942 · rdgdoc.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,669 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $65.50 to $66.41. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,500 | $23.56 | $176,700.00 |
DisclosureSEC source: 0001437749-23-013942 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| May 05, 2023 Filed May 9, 2023 15:18 UTC | ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497 | GrantCommon Stock · Derivative | 2,257 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028176 · doc4.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,257 Underlying: Common Stock · 2,257 shares Expires not disclosed F2 · shares: Represents an annual grant of restricted stock units on May 5, 2023 as the equity portion of non-employee directors' retainer for Board services under the 2023 Omnibus Incentive plan. The units vest on the one-year anniversary of the grant date contingent upon the Director's continued service upon such date. F3 · derivative.exercise_date: Restricted stock units are not exercisable. F4 · derivative.expiration_date: Restricted stock units do not have an expiration date. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 12:25 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.6595 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007966 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.6595 Underlying: Common Stock · 1.6595 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 12:25 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.083 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007966 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.6094 Underlying: Common Stock · 1.083 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 22:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 3,209 | $0.00 Strike: $47.19 | $0.00 |
DisclosureSEC source: 0001437749-22-029001 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,209 Underlying: Common Stock · 3,209 shares Expires 2027-12-12 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 22:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 593 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-029001 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,669 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $31.30 | $0.00 |
DisclosureSEC source: 0001437749-22-028344 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 7,500 | $46.65 | $349,840.50 |
DisclosureSEC source: 0001437749-22-028344 · rdgdoc.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,076 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $46.15 to $47.47. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,500 | $31.30 | $234,750.00 |
DisclosureSEC source: 0001437749-22-028344 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 01:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.5264 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-028474 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4.5264 Underlying: Common Stock · 1.5264 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:54 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-022219 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3 Underlying: Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:35 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-014417 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2 Underlying: Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 09, 2022 Filed May 11, 2022 20:28 UTC | ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497 | GrantCommon Stock | 2,655 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028310 · doc4.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,468 F1 · shares: Represents an annual grant of restricted stock units on May 9, 2022 as the equity portion of non-employee directors' retainer for Board services under the 2017 Omnibus Incentive Plan. The units vest on the one-year anniversary of the grant date contingent upon the Director's continued service upon such date. F2 · balance_after: Represents 2,655 unvested restricted stock units and 30,813 shares in common stock. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 01:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-007473 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Underlying: Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 11, 2021 Filed Dec 14, 2021 21:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 3,444 | $0.00 Strike: $48.60 | $0.00 |
DisclosureSEC source: 0001437749-21-028545 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,444 Underlying: Common Stock · 3,444 shares Expires 2026-12-11 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 11, 2021 Filed Dec 14, 2021 21:07 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 576 | $48.60 | $27,993.60 |
DisclosureSEC source: 0001437749-21-028545 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,076 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance besting in equal annual installments over the remaining two years. This award includes a provision for the withholding of shares by the issuer to pay the withholding taxes due upon each vesting date. Read SEC document |
| May 25, 2021 Filed May 26, 2021 22:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 357 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001437749-21-013446 · rdgdoc.xml · derivative · entry 6 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 357 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 25, 2021 Filed May 26, 2021 22:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 357 | $50.00 | $17,850.00 |
DisclosureSEC source: 0001437749-21-013446 · rdgdoc.xml · nonDerivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Read SEC document |
| May 25, 2021 Filed May 26, 2021 22:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 357 | $14.13 | $5,044.41 |
DisclosureSEC source: 0001437749-21-013446 · rdgdoc.xml · nonDerivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| May 24, 2021 Filed May 26, 2021 22:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,143 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001437749-21-013446 · rdgdoc.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357 Underlying: Common Stock · 7,143 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 24, 2021 Filed May 26, 2021 22:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 7,143 | $50.25 | $358,902.18 |
DisclosureSEC source: 0001437749-21-013446 · rdgdoc.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $50.00 to $50.68. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 24, 2021 Filed May 26, 2021 22:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,143 | $14.13 | $100,930.59 |
DisclosureSEC source: 0001437749-21-013446 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| April 30, 2021 Filed May 4, 2021 20:52 UTC | ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497 | GrantCommon Stock | 1,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029928 · doc4.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,813 F1 · shares: The restricted stock units granted on April 30, 2021 will vest 100% at the first anniversary date of the grant date. This is an annual non-employee director grant as outlined in the 2021 proxy. F2 · balance_after: As of this filing date, Mr. Roush holds 29,000 shares in street name. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 22:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 20,000 | $36.42 | $728,308.00 |
DisclosureSEC source: 0001437749-20-025124 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.25 to $36.71. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| December 02, 2020 Filed Dec 5, 2020 00:42 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001437749-20-024902 · rdgdoc.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2025-12-02 F1 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| August 26, 2020 Filed Mar 29, 2022 00:49 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | PurchaseCommon Stock | 30 | $31.06 | $931.73 |
DisclosureSEC source: 0001437749-22-007465 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 181 Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 01:25 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $11.43 | $0.00 |
DisclosureSEC source: 0001437749-20-015304 · rdgdoc.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2020-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 01:25 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,500 | $11.43 | $85,725.00 |
DisclosureSEC source: 0001437749-20-015304 · rdgdoc.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.